ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.